AU Professional photography pending
Qualifications MBBS, MD Nuclear Medicine (Gold Medal Hons.) · RSO
Joined TPPL 2024  ·  Senior Resident at FMRI
Trained at Tata Memorial Hospital, Mumbai
Specialty Molecular Oncology Imaging, Theranostics, AI in Imaging
Languages English, Hindi, Punjabi
Consult Dr. Uppal Second Read →
Senior Resident · Gold Medal · Tata Memorial alumnus

Dr. Abhishek Uppal, MBBS, MD

Senior Resident  ·  Department of Nuclear Medicine & Molecular Imaging  ·  FMRI Gurugram

"Gold Medal honours from Tata Memorial — and TPPL's emerging specialist in AI-driven precision oncology imaging."

Dr. Abhishek Uppal is a Senior Resident at the Department of Nuclear Medicine & Molecular Imaging, Fortis Memorial Research Institute (FMRI), Gurugram, where he joined Theranostic Physicians Private Limited (TPPL) in 2024. He completed his MD Nuclear Medicine at Tata Memorial Hospital, Mumbai — India's most renowned dedicated oncology institute — with Gold Medal honours. He is a qualified Radiation Safety Officer (RSO) and is currently pursuing certification in AI in Digital Health at the Indian Institute of Science (IISc), Bangalore, with active interest in AI research applications in precision oncology.

Professional biography

Tata Memorial Gold Medal honours, now applying AI to molecular imaging at TPPL.

Dr. Abhishek Uppal is a Senior Resident at the Department of Nuclear Medicine & Molecular Imaging, Fortis Memorial Research Institute, Gurugram, where he joined TPPL in 2024. He is a Nuclear Medicine Physician specialising in Functional & Molecular Imaging and Therapeutic Nuclear Medicine, and is actively involved in AI research in precision oncology.

Dr. Uppal completed his MBBS at Dayanand Medical College & Hospital, Ludhiana (2014–2020), followed by MD Nuclear Medicine at Tata Memorial Hospital, Mumbai (2020–2023), where he was awarded the Gold Medal with Honours. He continued at Tata Memorial as Senior Resident in Nuclear Medicine & Molecular Imaging from 2023 to 2024 before joining FMRI in 2024.

He is a qualified Radiation Safety Officer (RSO — Nuclear Medicine), certified in 2023. In parallel with his clinical role at FMRI, he is pursuing an AI in Digital Health certification at the Indian Institute of Science (IISc), Bangalore — one of India's premier scientific research institutions — reflecting his particular interest in the application of AI and machine learning to nuclear medicine imaging interpretation and theranostic patient selection.

His clinical interests include Molecular Oncology Imaging, Theranostics & Nuclear Medicine Therapy, Functional Imaging, and AI in Imaging & Patient Care. He is a co-author on the Springer Publications volume PET-CT in Non-Hodgkin Lymphoma.

Career timeline

From Tata Memorial Mumbai to FMRI Gurugram.

2024 —
Present

Senior Resident, Department of Nuclear Medicine & Molecular Imaging

Fortis Memorial Research Institute (FMRI), Gurugram · Theranostic Physicians Private Limited

Senior Resident at TPPL since 2024, working alongside Dr. Ishita B. Sen and the consultant team on molecular imaging, radioligand therapy administration, and AI-driven imaging research.

2023 —
2024

Senior Resident, Department of Nuclear Medicine & Molecular Imaging

Tata Memorial Hospital, Mumbai

Senior residency at India's most renowned dedicated oncology institute — deep clinical exposure to PET-CT, PRRT, radioiodine therapy, and theranostics across the full spectrum of solid and haematologic malignancies.

2020 —
2023

Junior Resident, Department of Nuclear Medicine & Molecular Imaging

Tata Memorial Hospital, Mumbai · MD Nuclear Medicine (Gold Medal Hons.)

Completed MD Nuclear Medicine at Tata Memorial Hospital, Mumbai — awarded the Gold Medal with Honours.

2014 —
2020

MBBS

Dayanand Medical College & Hospital, Ludhiana, Punjab
Education & certifications

Trained at Tata Memorial Mumbai, with ongoing AI work at IISc Bangalore.

Dr. Uppal combines clinical credentials from India's premier oncology institute with active certification in AI-driven digital health from one of India's foremost scientific research institutions.

2020 — 2023

MD Nuclear Medicine (Gold Medal Hons.)

Tata Memorial Hospital, Mumbai

Awarded the Gold Medal with Honours from India's most renowned dedicated oncology institute. Department of Nuclear Medicine & Molecular Imaging.

2014 — 2020

MBBS

Dayanand Medical College & Hospital, Ludhiana

2023

Radiation Safety Officer (RSO)

Atomic Energy Regulatory Board, India · Nuclear Medicine

Authorised RSO certification for nuclear medicine practice.

2023 — Present

AI in Digital Health Certification

Indian Institute of Science (IISc), Bangalore

Active ongoing certification at one of India's premier scientific research institutions — focused on AI applications in medical imaging and precision oncology.

Clinical interests

Areas of focused clinical and research interest.

Dr. Uppal's interests bridge classical nuclear medicine imaging with next-generation AI-driven applications in precision oncology. Each card links to a relevant TPPL therapy or service.

Molecular Oncology Imaging

PET-CT and SPECT-CT imaging across the full spectrum of solid tumours — staging, restaging, response assessment, and theranostic patient selection.

View all treatments

Theranostics & Nuclear Medicine Therapy

Lu-177 PSMA, Ac-225 PSMA, Lu-177 PRRT — the foundational radioligand therapies in modern theranostics.

View therapy

Functional Imaging

FDG, FAPI, somatostatin-receptor, and PSMA-targeted imaging for functional characterisation of disease beyond anatomical assessment.

View all treatments

AI in Imaging & Patient Care

Active research interest — AI/ML applications in nuclear medicine reporting, theranostic dosimetry, and precision-oncology patient selection. Concurrent IISc certification.

View upcoming

Lu-177 PRRT

Peptide receptor radionuclide therapy for somatostatin-receptor-positive neuroendocrine tumours — the established beta-emitter PRRT protocol.

View therapy

Precision Oncology Imaging

Combining molecular imaging biomarkers with AI-driven analytics for individualised treatment selection in advanced cancers.

View upcoming therapies

PET-CT in Lymphoma

Co-author on Springer Publications' PET-CT in Non-Hodgkin Lymphoma — FDG-PET interpretation for lymphoma staging, response assessment, and surveillance.

View publications

PET-CT Second Read

Independent expert second-read of PET-CT scans — available for patients seeking a second opinion on a previously-reported scan.

Second Read service

FAPI Theranostics

Fibroblast Activation Protein Inhibitor imaging and therapy — next-generation pan-tumour stromal targeting.

View therapy
Published work

Springer Publications co-author on PET-CT in Non-Hodgkin Lymphoma.

Dr. Uppal's published work spans collaborative chapter authorship and ongoing research presentations. For the full TPPL team research output, see the Publications hub.

Book Springer
Co-author

PET-CT in Non-Hodgkin Lymphoma

Springer Publications · Co-authorship on a Springer-published volume on FDG-PET-CT applications in non-Hodgkin lymphoma staging, response assessment, and surveillance.

Publications →
In Progress IISc
Ongoing research

AI in Digital Health Certification — Indian Institute of Science, Bangalore

Active ongoing research interest in AI/ML applications to nuclear medicine imaging and theranostic patient selection.

Publications →

Medical disclaimer All physicians and researchers profiled on this page hold appointments at the Department of Nuclear Medicine & Molecular Imaging, Fortis Memorial Research Institute, Gurugram. Theranostic Physicians Private Limited (TPPL) is the clinical practice entity through which they consult and treat patients. Treatment outcomes vary by individual case; clinical decisions are made on the basis of complete medical records, current imaging, and a multidisciplinary review.